FDA Proposes Guidance for Dissemination of Information on Unapproved Uses
FDA Proposes Guidance for Dissemination of Information on Unapproved Uses of Medical Products
The U.S. Food and Drug Administration (FDA) today issued draft guidance on "Good Reprint Practices" for industry use in the distribution of medical or scientific journal articles and reference publications that involve unapproved uses of FDA-approved drugs and medical devices.